In Vitro Method for Diagnosing Prostate Cancer
AssigneeCommissariat a l'Energie Atomique
InventorsClaude Cochet, Odile Filhol, Mathieu Laramas
Life of this patent
Estimating the term…
Abstract
The invention relates to an in vitro method for diagnosing prostate cancer and to antibodies and fragments thereof directed against CK2-α and their use for the diagnosis and prognosis of prostate cancer.
Claims13
An in vitro method for diagnosing prostate cancer in a subject, said method comprising measuring the CK2-α level in a prostatic cell obtained from a biological sample of said subject.
An antibody or a fragment thereof which specifically binds to a CK2-α epitope as set forth in SEQ ID NO:1.
9-12. (canceled)
A method for detecting CK2-α, said method comprising using an antibody or a fragment thereof which specifically binds to a CK2-α epitope as set for in SEQ ID NO:1.
(canceled)
A kit for diagnosing cancer, comprising an antibody or a fragment thereof which specifically binds to a CK2-α epitope as set forth in SEQ ID NO:1.
A method for diagnosing cancer, said method comprising the step of using an antibody or a fragment thereof which specifically binds to a CK2-α epitope as set forth in SEQ ID NO:1.
Dependencies are inferred from the claim text.